Drugmakers need to learn empathy and not try to defend price hikes that make drugs inaccessible, GSK CEO Andrew Witty told CNBC.
Drugmakers need to learn empathy and not try to defend price hikes that make drugs inaccessible, GSK CEO Andrew Witty told CNBC.